Publicacions
-
Rosel, P., Arranz B, Oros, M., Vallejo, J., San L, Marcusson, J. and Navarro, M.A..
Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain.
NEUROSCIENCE RESEARCH COMMUNICATIONS . 24(2): 107-115. Nº de cites: 5
[doi:10.1002/(SICI)1520-6769(199903/04)24:2<107::AID-NRC6>3.0.CO;2-Y]
-
Rosel, P, Arranz B, Vallejo, J, Alvarez, P, Menchon, JM, Palencia, T and Navarro, MA.
Altered [H-3]imipramine and 5-HT2 but not [H-3]paroxetine binding sites in platelets from depressed patients
JOURNAL OF AFFECTIVE DISORDERS . 52(1-3): 225-233. Nº de cites: 34
-
San L, Arranz B and Cebamanos, J.M..
The pharmacological treatment of alcoholism
Revisiones en Psicofarmacologia . 3(1): 19-29.
-
San L and Arranz B.
Monitoring patterns of substance use in drug-dependent patients
JOURNAL OF SUBSTANCE ABUSE TREATMENT . 15(5): 425-430. Nº de cites: 5
-
Rosel, P, Arranz B, Vallejo, J, Oros, M, Crespo, JM, Menchon, JM and Navarro, MA.
Variations in [H-3]imipramine and 5-HT2A but not [H-3]paroxetine binding sites in suicide brains
PSYCHIATRY RESEARCH-NEUROIMAGING . 82(3): 161-170. Nº de cites: 39
-
Arranz B, Rosel P, San L, Sarró S, Navarro MA and Marcusson J.
Characterization of the 5-HT4 binding site in human brain.
JOURNAL OF NEURAL TRANSMISSION . 105(6-7): 575-586. Nº de cites: 14
-
Machuca I, Ibañez-Toda L, Bonnín MR, Rosel P, Arranz B and Navarro MA.
Routine detection of point mutations in non-classic steroid 21-hydroxylase
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH . 27(4): 257-260. Nº de cites: 2
-
Arranz B and San L.
Dependencia de alcohol y sistema serotoninrgico: implicaciones teraputicas.
MEDICINA CLINICA . 109(15): 599-605. Nº de cites: 4
-
Rosel, P, Menchon, JM, Vallejo, J, Arranz B, Navarro, MA, Liron, F and Alvarez, P.
Platelet [H-3]imipramine and [H-3]paroxetine binding in depressed patients
JOURNAL OF AFFECTIVE DISORDERS . 44(1): 79-85. Nº de cites: 17
-
Arranz B, Blennow K, Eriksson A, Månsson JE and Marcusson J.
Serotonergic, noradrenergic, and dopaminergic measures in suicide brains.
Biological Psychiatry . 41(10): 1000-1009. Nº de cites: 38